2018
-
Company halts drug trial for rare disease
Capricor Therapeutics has announced that it is stopping progress on a trial for a new Duchenne muscular dystrophy treatment.
12/27/2018 -
Russia looks to legalize medical poppy production
In the wake of ongoing sanctions from the West that have limited Russia’s access to narcotic crops, Russia is looking to make its own.
12/27/2018 -
Acorda nabs crucial FDA ok for Parkinson’s drug
Acorda Therapeutics announced that the U.S. FDA approved Inbrija for intermittent treatment of OFF episodes in people with Parkinson’s disease treated with carbidopa/levodopa.
12/26/2018 -
Biotech billionaire builds “new-wave” pharma company
Japanese billionaire Hiroshi “Mickey” Mikitani has raised a total of $284 million to back his biotech startup.
12/21/2018 -
Novartis oncology CEO makes hasty exit
Just 11 months after taking on the role, Novartis oncology chief Liz Barrett said she is leaving to become chief executive of a U.S. biotech company.
12/20/2018 -
Recipharm could shutter UK facility, threatening 140 jobs
One of the industry’s leading CDMOs is exploring the possibility of closing its solid dose manufacturing facility in Ashton-under-Lyne, UK.
12/20/2018 -
Sen. Warren floats bill to create government-run generics manufacturing company
The bill comes as Warren gears up for a potential presidential run in 2020.
12/18/2018 -
AstraZeneca drug gets OK’d in China before the West
For the first time, China’s medicines regulator has approved a new drug from a multinational company before regulators in the U.S. or EU.
12/18/2018 -
Lilly drug shown to be more effective than Humira in late-stage study
Eli Lilly Co. released results from a study this week showing that its drug, Taltz, was better at treating psoriatic arthritis than Humira.
12/17/2018 -
Taisho could be closing in on $1.6B deal with BMS
Taisho Pharmaceutical Holdings Co. is reportedly in talks with Bristol-Myers Squibb about a deal that could be work $1.6 billion.
12/17/2018 -
Innovent drops $40M on Incyte drugs in China
Innovent Biologics and Incyte have entered into a strategic collaboration agreement for three clinical-stage product candidates discovered and developed by Delaware-based Incyte.
12/17/2018 -
Amgen ends Advaxis immuno-oncology deal
Amgen has terminated its collaboration with New Jersey-based Advaxis on an immuno-oncology program.
12/14/2018 -
Regulator confirms Sun Pharma whistleblower complaint
The Securities Exchange Board of India (Sebi) has confirmed reports that it had received a whistleblower complaint against Sun Pharma.
12/13/2018 -
J&J throws shade at rival Novartis with psoriasis study
Johnson & Johnson says that its psoriasis medication, Tremfya, is more effective than another treatment developed by Novartis AG.
12/12/2018 -
FDA rejects reformulated opioid
Mallinckrodt announced this week that the FDA will not approve an abuse-deterrent version of the company’s opioid product, Roxicodone.
12/12/2018 -
Pfizer plant in Kansas repeatedly hit with form 483 infractions
Since 2012, Pfizer's Hospira plant in Kansas has received eight citations including infractions for cardboard in samples and failures to conduct investigations into discrepancies in batches of finished products
12/11/2018 -
Boehringer cuts nearly 300 jobs in France
The company's French workforce will see 327 jobs cut but will also see 32 new ones created.
12/11/2018 -
Dozens of generics companies investigated for running alleged ‘cartel’
An antitrust investigation that initially focused on two drugs has now widened to include 300 drugs and at least 16 companies.
12/10/2018 -
Lonza makes plans for major biomanufacturing plant in China
Swiss CDMO giant Lonza announced Monday that it’s partnering with GE Healthcare to build a new biomanufacturing facility in China.
12/10/2018 -
AstraZeneca partners on cancer tech center
AstraZeneca announced a new collaboration with Cancer Research UK to launch a center of excellence in genetic screening, cancer modeling and big data processing
12/10/2018